A composition for, and method of making, a functional electrolyte beverage providing total cation fluid concentration of about 585.5-2342 mg/l is described. The method comprises: combining edible sodium, potassium, calcium and magnesium salts to obtain a first mixture; combining edible organic acids to obtain a second mixture; combining water, emulsifier, sweetener, flavor, pasteurized fruit or vegetable juice concentrate, vitamins, minerals and other added nutrients to obtain a third mixture; combining the first three mixtures to obtain a fourth mixture in the form of an emulsion concentrate; and diluting the fourth mixture with water to obtain the final beverage composition.

The present invention provides a method of concentrating a cyclolanostane compound and a lophenol compound in an aloe powder. In the present invention, the aloe powder is produced by soaking aloe mesophyll in hot water and drying and pulverizing the aloe mesophyll recovered from the hot water.

The present invention provides a method of concentrating a cyclolanostane compound and a lophenol compound in an aloe powder. In the present invention, the aloe powder is produced by soaking aloe mesophyll in hot water and drying and pulverizing the aloe mesophyll recovered from the hot water.

The present disclosure relates to a composition for ameliorating a circulatory system disease, which contains a green tea extract with modified ingredient content. According to the present disclosure, it is possible to effectively prevent, ameliorate and treat circulatory system diseases without side effects and, thereby, to greatly help patients with circulatory system diseases and contribute to the development of related industries.

Provided herein are methods for producing formulations for incorporation into clear beverages. A variety of solutes may be microencapsulated to provide a formulation that results in a clear solution upon addition to water. Microencapsulation may be achieved by, for example, spray drying. Also provided herein are microencapsulated products and solutions of microencapsulated products in water.

Provided herein are methods for producing formulations for incorporation into clear beverages. A variety of solutes may be microencapsulated to provide a formulation that results in a clear solution upon addition to water. Microencapsulation may be achieved by, for example, spray drying. Also provided herein are microencapsulated products and solutions of microencapsulated products in water.

The present invention is a cannabidiol (CBD), cannabigerol (CBG) or related cannabinoid oral dosage form including bacterially fermented hemp, typically compounded as a tablet or formulated within a capsule or as an additive to other dietary supplements or functional foods. The dosage forms contain dietary fiber, important to activity as the desired delivery system, having a ratio of one part soluble dietary fiber to 30 parts insoluble dietary fiber, which is an optimal fiber ratio for oral delivery and bioavailability of cannabidiol, cannabigerol and other desirable cannabinoids from either activated or native hemp.

A compartmentalized water soluble beverage pod for facile beverage preparation includes a plurality of secondary shells that is coupled to a primary shell. The primary shell defines an interior space and each secondary shell defines an associated internal space. The primary shell and the plurality of secondary shells are water soluble. An associated substance, which comprises at least one of a beverage concentrate, a sweetening agent, a creamer concentrate, and a flavoring agent, is positioned in each of the interior space and the internal spaces. The primary shell and the plurality of secondary shells are configured to dissolve when positioned in water so that the associated substances are released to dissolve in the water to form a beverage.

A compartmentalized water soluble beverage pod for facile beverage preparation includes a plurality of secondary shells that is coupled to a primary shell. The primary shell defines an interior space and each secondary shell defines an associated internal space. The primary shell and the plurality of secondary shells are water soluble. An associated substance, which comprises at least one of a beverage concentrate, a sweetening agent, a creamer concentrate, and a flavoring agent, is positioned in each of the interior space and the internal spaces. The primary shell and the plurality of secondary shells are configured to dissolve when positioned in water so that the associated substances are released to dissolve in the water to form a beverage.

A method of treating or preventing dehydration in an individual having impaired swallowing such as dysphagia can include administering to the individual having the dysphagia an effective amount of a composition containing a salivating agent and a cooling agent in a weight ratio of 1:0.06 to 1:0.2. Optionally the composition includes a tingling agent. The composition can be a powder that is reconstituted before administration, for example at the point of consumption. A thickening or thin cohesive agent can be included in the powder and/or can be included in a liquid in which the powder is reconstituted. The composition can be a beverage containing the salivating agent and the cooling agent in a total amount of at least 3.0 wt. % of the beverage, for example at least 6.0 wt. % of the beverage. The composition can be a ready-to-drink beverage or a frozen dessert on a stick.